Maria João Bonifácio

Author

Also Known As

Bonifácio, Maria, M Bonifacio, M Bonifcio, M J Bonifácio, M. J. Bonifácio, M.-J. Bonifacio, M.J. Bonifacio, M.J. Bonifácio, MARIA JOÃO BONIFÁCIO, Maria Bonifácio

111

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Bial (Portugal)Universidade do Porto University of Beira Interior University of Aveiro Instituto Português de Oncologia Francisco Gentil

About

Maria João Bonifácio is an author at Bial (Portugal) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	20	754
2	Biochemistry	12	14	475
3	Natural Sciences	11	11	418
4	Engineering	6	6	119
5	Social Sciences	2	2	145

Maria João Bonifácio

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Discovery of a Long-Acting, Peripherally Selective Inhibitor of Catechol-<i>O</i>-methyltransferase László E. Kiss, Humberto Ferreira, Leonel Torrão, Journal of Medicinal Chemistry Bioorganic ChemistryPharmacotherapyChemical BiologyPharmaceutical ChemistryMolecular Pharmacology	2010	164
Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: A comparison with carbamazepine, oxcarbazepine and lacosamide Simon Hebeisen, Nuno Pires, Ana I. Loureiro, Neuropharmacology NeurophysiologyMedicinePhysiologyAnesthetic MechanismIon Channels	2014	133
Interaction of the Novel Anticonvulsant, BIA 2‐093, with Voltage‐Gated Sodium Channels: Comparison with Carbamazepine Maria João Bonifácio, R.D. Sheridan, António Parada, Epilepsia	2001	96
Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug Anna Doeser, G. Dickhof, Margit Reitze, Brain	2014	88
Kinetics and Crystal Structure of Catechol-O-Methyltransferase Complex with Co-Substrate and a Novel Inhibitor with Potential Therapeutic Application Maria João Bonifácio, Margarida Archer, Maria Luı́sa Rodrigues, Molecular Pharmacology	2002	86
Pharmacokinetics, Pharmacodynamics and Tolerability of Opicapone, a Novel Catechol-O-Methyltransferase Inhibitor, in Healthy Subjects Luís Almeida, José Rocha, Amílcar Falcão, Clinical Pharmacokinetics Healthy SubjectsNovel Catechol-o-methyltransferase InhibitorActive IngredientMedicinePharmacological Study	2012	86
Opicapone: a short lived and very long acting novel catechol‐<scp>O</scp>‐methyltransferase inhibitor following multiple dose administration in healthy subjects José Rocha, Luís Almeida, Amílcar Falcão, British Journal of Clinical Pharmacology	2013	85
Pharmacological profile of opicapone, a third‐generation nitrocatechol catechol‐<scp><i>O</i></scp>‐methyl transferase inhibitor, in the rat Maria João Bonifácio, Leonel Torrão, Ana I. Loureiro, British Journal of Pharmacology	2014	53
Comparative Study of ortho- and meta-Nitrated Inhibitors of Catechol-O-methyltransferase: Interactions with the Active Site and Regioselectivity of O-Methylation P. Nuno Palma, Mariana Lins Rodrigues, Margarida Archer, Molecular Pharmacology	2006	51
Computation of the binding affinities of catechol‐<i>O</i>‐methyltransferase inhibitors: Multisubstate relative free energy calculations P. Nuno Palma, Maria João Bonifácio, Ana I. Loureiro, Journal of Computational Chemistry Free Energy ChangesTarget EnzymeMolecular BiologyComputational ChemistryProtein Folding	2012	50

Page 1